OpenVSafe by OpenVAERS
Search V-safe

S43-23775-46695

2 vaccinations 4 coded responses 18 check-ins 4 free-text entries 4 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
152 / PA
Registered
2020-12-29
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-29
    Registered in v-safe
  2. 2020-12-29
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-29
    Survey response — day 0, dose 1
    MedDRA: Dysgeusia — Feeling: Good · Site: Pain · Fatigue or tiredness
    Free text: Metallic taste following vaccination and for about 3 hours afterwards
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2020-12-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  5. 2020-12-30
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  6. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  7. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  8. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  9. 2021-01-04
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  10. 2021-01-07
    Health check-in — day 7, dose 1
    Feeling: Fair · Joint pains, Muscle or body aches · Be unable to do your normal daily activities
    Adult check-in
  11. 2021-01-07
    Report sent to call center — day 7, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  12. 2021-01-12
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-01-18
    Dose 2 — Pfizer-BioNTech
  14. 2021-01-18
    Survey response — day 0, dose 2
    MedDRA: Dysgeusia — Feeling: Good · Site: Pain
    Free text: Weird taste in mouth after vaccination
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-01-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  16. 2021-01-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  17. 2021-01-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Diarrhea, Abdominal pain
    Adult check-in
  18. 2021-01-27
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-04
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-08
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-17
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-04-19
    Survey response — 3 months, dose 2
    MedDRA: Oligomenorrhoea — Feeling: Good · Be unable to do your normal daily activities
    Free text: I now get severe car sickness (even on short rides) which Ive never experienced before.My periods are also much longer
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-07-21
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  24. 2022-01-19
    Survey response — 12 months, dose 2
    MedDRA: Abdominal lymphadenopathy, Abdominal pain, Discomfort, Pelvic pain — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Weeks of pelvic and abdominal pain/pressure. Mesenteric lymphadenopathy. Still trying to figure out cause. Possibly gynecological or new onset IBD. Still unknown as of now.
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-01-19
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  26. 2022-01-19

Vaccinations

DoseDateManufacturerCo-administered
12020-12-29Pfizer-BioNTech
22021-01-18Pfizer-BioNTech

Call center

4 call center cases

1 unsuccessful · 3 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — day 0, dose 1

2020-12-29

Systemic reaction (other): Metallic taste following vaccination and for about 3 hours afterwards

Release 2 — day 0, dose 2

2021-01-18

Systemic reaction (other): Weird taste in mouth after vaccination

Release 7 — 3 months, dose 2

2021-04-19

Symptoms: I now get severe car sickness (even on short rides) which Ive never experienced before.My periods are also much longer

Release 10 — 12 months, dose 2

2022-01-19

Symptoms: Weeks of pelvic and abdominal pain/pressure. Mesenteric lymphadenopathy. Still trying to figure out cause. Possibly gynecological or new onset IBD. Still unknown as of now.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal lymphadenopathy · · ✓
SDAbdominal pain · · ✓
SDDiscomfort · · ✓
SDOligomenorrhoea ✓ ✓ ✓
SDPelvic pain · · ✓
SRODysgeusia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release